Arteris sells network‑on‑chip interconnect IP and system IP that sit at the heart of modern SoCs and chiplets. Its technology is used by 9 of the top 10 semiconductor companies, spans 975+ confirmed design starts and over 4 billion chips shipped historically.
The business is asset‑light with very high gross margins and growing remaining performance obligations, supported by record ACV plus royalties and a 21% year‑over‑year increase in trailing‑twelve‑month confirmed design starts through June 30, 2026. These indicators suggest durable switching costs and efficient scale in a specialized niche that benefits from the secular shift to AI and multi‑die designs.
Financially, Arteris is transitioning from losses toward sustained cash generation. For the quarter ended June 30, 2026, revenue rose 46% year over year to 24.1 million with 85% gross margin, free cash flow of 8.6 million for the quarter, and RPO reached 134.9 million, up from 99.3 million a year earlier.
TTM free cash flow through Q2 2026 is approximately 6.8 million when reconciled from GAAP cash flows. The balance sheet holds roughly 120 million of net cash and investments against minimal vendor‑financing liabilities, providing resilience while the company invests in R&D and integrates the Cycuity hardware‑security acquisition.
Non‑GAAP profitability is targeted for 2026 with full‑year free‑cash‑flow guidance of 5 to 9 million.
Moat components and weights: Switching costs (40% weight, score 85): once a NoC is embedded into a customer’s SoC architecture and flows, replacing it is costly and risky, which tends to lock in platforms across multiple generations and drives long tail royalties. The company explicitly notes significant switching costs once designed into projects.
Intangibles (25% weight, score 75): the firm reports 148 patents with 138 applications, a long track record in NoC, and is used by 9 of the top 10 semiconductor companies across 975+ design starts and >4B units shipped, which reinforces know‑how and credibility.
Efficient scale (15% weight, score 75): the dedicated NoC vendor landscape has consolidated after Intel bought NetSpeed and Facebook bought Sonics, leaving Arteris as the primary independent specialist serving a relatively small but global niche. That scale and focus deter new entrants.
Network effects (10% weight, score 60): not a classic network, but there are soft effects through ecosystem integrations and reference wins that increase tool familiarity and IP interoperability over time.
Cost advantage (10% weight, score 55): high gross margins show product value but do not indicate a structural cost edge versus internal development at very large customers or versus Arm’s integrated offerings.
Overall, we see a narrow‑to‑moderate moat anchored in switching costs and efficient scale, with durability supported by rising complexity in AI and multi‑die architectures, yet still exposed to well‑funded competitors.
Arteris posts very high gross margins (about 85% in Q2 2026), reflecting strong perceived value. Pricing power is supported by customer lock‑in and the small bill‑of‑materials share relative to the economic value of a working SoC, especially in safety‑critical and AI designs.
That said, large customers possess negotiation leverage and Arm’s interconnect options cap unilateral price hikes. We expect selective price increases tied to new features, safety and security assurance, and chiplet workflows rather than broad rate hikes.
Visibility is above average for a small cap IP vendor due to multi‑year license terms, ratable revenue recognition and a growing backlog.
RPO stood at 134.9 million as of June 30, 2026, up from 99.3 million a year earlier, and management reported a 21% year‑over‑year increase in trailing‑twelve‑month confirmed design starts through Q2 2026. However, royalty timing remains tied to end‑market production ramps and can be lumpy, and exposure to macro cycles and China introduces variability.
We therefore view predictability as good but not visa‑like.
The balance sheet is strong with approximately 123 million in cash and investments at June 30, 2026 and only about 3.5 million of vendor‑financing liabilities, implying roughly 120 million net cash.
The company generated positive operating cash flow of 2.1 million in 1H 2026 and posted quarterly free cash flow of 8.6 million in Q2 2026. TTM free cash flow through Q2 2026 is about 6.8 million when reconciling FY 2025 and 1H 2026 GAAP cash flows and capex.
Deferred revenue is large and rising, but also reflects performance obligations that require continued delivery. Overall liquidity looks ample for R&D and integration needs.
Positives: disciplined emphasis on organic R&D and field application engineering to expand product breadth and ease of deployment, plus a strategically coherent acquisition of Cycuity to add hardware security assurance across the SoC lifecycle.
Negatives: dilution stepped up in 1H 2026 via an at‑the‑market equity program raising about 72.5 million, and non‑GAAP operating losses persist as the company scales. We expect continued selective M&A and reinvestment ahead of sustained profitability. On net, strategy is sound but dilution and the timing to full profitability temper the score.
Founder‑operator dynamics and insider alignment are strong. CEO and Chair K. Charles Janac beneficially controls a significant stake, with approximately 21.6% voting power noted in filings, which aligns decisions with long‑term value creation. Execution credibility is supported by deep institutional customer ties.
Near‑term, the announced retirement of long‑time CFO Nick Hawkins (effective August 31, 2026) is a transition risk that warrants monitoring. Overall leadership quality is solid with clear product vision, though succession in finance will be important.

Is Arteris a good investment at $24?
The following analysis is provided for informational and educational purposes only. It does not constitute financial advice, investment advice, or a recommendation to buy or sell any security. The opinions expressed are based on publicly available information and historical data. Beanvest and its contributors may hold positions in the securities mentioned. Investors should conduct their own due diligence or consult a licensed financial advisor before making any investment decision.